Clevidipine-d7

SL-10340

Clevidipine-d7, >98%

IUPAC Name : 3-(((Butanoyl-d7)oxy)methyl) 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Clevidipine-d7 is a deuterium-labelled version of Clevidipine. This can be used as an analytical labelled reference standard. Clevidipine is a selective, short-acting L-type calcium channel blocker that causes rapid vasodilation by inhibiting extracellular calcium influx, lowering peripheral vascular resistance, and effectively controlling acute severe hypertension. It also helps protect the myocardium from reperfusion injury by increasing nitric oxide release. Clevidipine is useful for studying acute hypertension, perioperative blood pressure control, and myocardial ischemia-reperfusion injury.

References : Pollack C. V. et al.: Ann Emerg Med., 53(3), 329-38, 2009; Gourine A. et al.: Cardiovasc Res., 51(1), 100-7, 2001; Wang Y. et al.: Biomed Chromatogr., 32(2), 2018; Wisniowska B. et al.: J. Appl Toxicol., 32(10), 858-66, 2012.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.